Skip to main content

Closed

ATNM: Actinium Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.73×avg

Market Cap

25.41MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Actinium Pharmaceuticals, Inc.

ATNMNew York Stock Exchange Arca·USD·Closed

Actinium Pharmaceuticals, Inc.

ATNMNew York Stock Exchange Arca·USD·Closed

$0.81

−0.18%

$0.81

−$0.00 (0.18%)

52W Range

0thpctl

Volume

0.73×avg

Mkt Cap

25.41MUSD

P/E

-1.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings